Question.4826 - Application 3 is due before 830pm (eastern standard time). Please see the assignments section of this course for a detailed description of all assignments. In order to earn full credit for this or any assignment, you must follow all directions, include whatever information is required and post before the due date. Please note that some of the assignments require that you reply to other students in the course.This assignment will take quite a bit of time as measurement must occur over a period of time (hence it is worth 20% of your grade) so please start work early.Please note that for this assignment you will be posting information that 1) I read; 2) other students must read and 3) is stored in a non-HIPAA compliant website. You may NOT use a real client for this assignment. Your work (paper) will not be confidential. In fact, I suggest that you do not use the person's real name in the paper - change it for their privacy.
Answer Below:
Application xxxxx PTSD xxxxxxxxxx Using xxxx PSYM xxxxxxxx Methods xxx Program xxxxxxxxxxxxxxx IntroductionThis xxxxx is xxxx of xxxxxxxxxxx in xxxxxxxxx Practice xxx PSYM xxx objective xx this xxxxxx is xx implement x clinical xxxxxxxxxx tool xx administering xxxxxxx and xxxxxxxxx the xxxxxxx of xxx Post-Traumatic xxxxxx Disorder xxxxxxxxx for xxxx PCL- xxxx measure xxx selected xxx to xxx effectiveness xx assessing xxx tracking xxxx symptoms xx a xxxxxxxxxx and xxxxxxxxx manner xxx following xxxxxxxx outline xxx assessment xxxxxxx the xxxxxxxxxxx s xxxxxxx progression xxx an xxxxxxxx of xxx results xx a xxxxxxxx setting xxxx of xxx Measure xxxxxxx instrument xxxxxx for xxxx application xx the xxxxxxxxxxxxxx Stress xxxxxxxx Checklist xxx DSM- xxxx This xxxxxxxxxx tool xxxxxxxxx PTSD xxxxxxxx in xxxxxxxxxxx who xxxx experienced xxxxxxxxx events xx is xxxxxx utilized xx clinical xxx research xxxxxxxx due xx its xxxxxx psychometric xxxxxxxxxx What xx MeasuresThe xxxx assesses xxxx symptoms xxxxxx four xxxxxxx symptom xxxxxxxx Re-experiencing x g xxxxxxxxx thoughts xxxxxxxxxxx dreams xxxxxxxxxx Avoidance x g xxxxxxxx trauma-related xxxxxxxx or xxxxxxxxx Negative xxxxxxxxxxx in xxxxxxxxx and xxxx e x feelings xx detachment xxxxxxxxxx negative xxxxxxxx Hyperarousal x g xxxxxxxxxx startle xxxxxx irritability xxxx scores xxxxx from xx with x threshold xx or xxxxxx suggesting x probable xxxx diagnosis xxxxxxxx and xxxxxxxxxxx StatisticsThe xxxx has xxxxxxxxxxxx strong xxxxxxxxxxx and xxxxxxxx in xxxxxxxx studies xxxxxxxx Consistency xxxxxxxx s xxxxx Typically xxxxxx from xx indicating xxxx reliability xxxxxxxxxxx Reliability xxxxxx range xxxxxxx and xxxxxxx consistent xxxxxxxxx over xxxx Convergent xxxxxxxx The xxxx has x strong xxxxxxxxxxx with xxxxx PTSD xxxxxxxxxx tools xxxxxxxxxxx its xxxxxxxx accuracy xxxxxxxx et xx Hinde xx al xxxx Frame xxx AdministrationFor xxxx study xxx PCL- xxx administered xxxxx over x five-day xxxxxx This xxxxxx was xxxxxx to xxxxx variations xx symptom xxxxxxxx within x short xxxxxxxxx while xxxxxxxx consistency xx assessment xxxxxxxxxx Scores xxxxxxxxxxxxxxxx ScorePTSD xxxxxxxx LevelDay xxxxx Moderate xxxxxxx March xxxxxxxx PTSDDay xxxxx Moderate xxxxxxx March xxxxxx PTSDDay xxxxx Severe xxxxxxxxxxxx of xxxxxx Over xxxxxxx participant x scores xxxxxx a xxxxxxx increase xx PTSD xxxxxxx severity xxxx the xxxxxxxx assessment xxxxxx The xxxxxxx score xx Moderate xxxx progressively xxxx to xxxxxx PTSD xxxxxxxxxx a xxxxxxxxx increase xx emotional xxxxxxxx This xxxxxxxxxx could xx attributed xx external xxxxxxxxx or xxxxxxxxxx emotional xxxxxxxxx resulting xxxx daily xxxxxxx tracking xxx results xxxxxxxxx the xxxxxxxxxx of xxxxxxx monitoring xx detect xxxxxxx trends xxxx may xxxxxxxxxxx intervention xxxxxxxxxxxxx PCL- xxxxxx to xx an xxxxxxxxx tool xxx assessing xxxx symptoms xxxx time xxx increasing xxxxx in xxxxxxx severity xxxxxxxxxx the xxxx for xxxxxx intervention xxxxxxxxxx such xx cognitive-behavioral xxxxxxx CBT xxxxxxxxxxx practices xxx supportive xxxxxxxxxx This xxxxxxxxxxx demonstrates xxx importance xx structured xxxxxxxx assessments xx identifying xxxxxxx progression xxx guiding xxxxxxxxxxx treatment xxxxxxxxxx to xxxxxxx mental xxxxxxxxxx ReferencesCorcoran x Fischer x Measures xxx Clinical xxxxxxxx and xxxxxxxx A xxxxxxxxxx Oxford xxxxxxxxxx Press xxxxxx S x Raudales x M xxxxxxxxx H x Weiss x H xxxxxxx B x Contractor x A xxx Posttraumatic xxxxxx Disorder xxxx Checklist xxx DSM x systematic xxxxxx of xxxxxxxx psychometric xxxxxxxx Clinical xxxxxxxxxx Science xxx Practice xxxxx K xxxx G x Hallford x Gilmour x Arendt x Pavan x Austin x Post-Traumatic xxxxxx Symptoms xx Australian xxxxxxx of xxxxxxxx Children xxxxxx Structure xx the xxxxxxxxxxxxx Trauma xxxxxxxxxxxxx ITQ xxx the xxxxxxxxxxxxxx Stress xxxxxxxx Checklist xxx DSM- xxxx Available xx SSRNMore Articles From SP25MI Res Meth & Prgm Eval (PSYM-525- A)
.ico)
.ico)
.ico)
.ico)
